Androgen deprivation of prostate cancer: Leading to a therapeutic dead end-Reference-Cited by-同舟云学术

Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

Published:2015-10 Issue:1 Volume:367 Page:12-17
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Katzenwadel Arndt,Wolf Philipp

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference97 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J. Clin,2014

2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur. J. Cancer,2013

3. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

4. Novel therapeutic strategies for androgen-independent prostate cancer: an update;Assikis;Semin. Oncol,2004

5. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy;ACS Pharmacology & Translational Science;2024-08-12

2. Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines;International Journal of Molecular Sciences;2024-08-07

3. Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism;2024-07-19

4. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8;Advanced Science;2024-06-23

5. Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent;Molecular Therapy - Nucleic Acids;2024-06